Drug Trial Radar · NCT06845306
The Use of Indocyanine Green Near-infrared Fluorescence for Bowel Perfusion Quantitative Assessment in Order to Prevent Anastomotic Leakage in Colorectal Surgery
Last checked: Nov 19, 2026Latest source record: Feb 25, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
1,268
Planned (sponsor's estimate)
Start
Jun 1, 2025
Primary completion
Jul 1, 2026
Study completion Sep 1, 2026
Sponsor
- Lead sponsor
- Vadim KuznetsovResearch network
- Sponsor type
- Research network
- First posted
- Feb 25, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (participant)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Anastomotic leakage (AL) is a serious complication after surgery for colon cancer, leading to a significant increase in mortality.Intraoperative fluorescence imaging using indocyanine green has proven to be a feasible and reproducible technique for real-time perfusion assessment. An increasing number of studies are being published on the use of indocyanine green (ICG) fluorescence imaging in colorectal cancer surgery, showing promising results. Therefore, we propose conducting a multicenter, randomized controlled trial to investigate the potential use of quantitative assessment of near-infrared fluorescence imaging with indocyanine green (ICG) to prevent anastomotic leaks during colorectal surgery.
Conditions
- Colo-rectal Cancer
- Colonic Neoplasms Malignant
Interventions
ICG-guided bowel perfusion assessmentDrug
ICG will be injected before anastomosis is created, to quantitatively assess the perfusion status of the bowel.
Conventional Bowel Anastomosis groupOther
conventional perfusion assessment
Primary outcomes
What the sponsor says the trial is designed to measure.
- 30-days Anastomotic Leakage (AL) rateTime frame: 30-days
Locations
1 site in 1 country. Site status is shown where the registry gives one.
BELOOSTROV Clinic of High Technologies
Vsevolozhsk District, Leningradskaya Oblast', Russia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.